Bio-Rad Labs (BIO) Misses Q4 EPS by 16c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $270.32 -3.84%
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $3.31, $0.16 worse than the analyst estimate of $3.47. Revenue for the quarter came in at $730.3 million versus the consensus estimate of $747.26 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
